Moreover, CD8+TILs from mice with HPD demonstrated impaired function and high TOX expression, and TIM-3 and PD-1 co-blockades could enhance the anti-tumor immunity of CD8+TILs. The gene discussed is HAVCR2; the disease is neoplasm.